Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,883 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Costs and Clinical Consequences of Compliance with COPD GOLD Recommendations or National Guidelines Compared with Current Clinical Practice in Belgium, Germany, Sweden, and the United States.
Sethi S, Wright A, Hartgers-Gubbels ES, Hechtner M, Clark B, Wright C, Langham S, Buhl R. Sethi S, et al. Among authors: clark b. Int J Chron Obstruct Pulmon Dis. 2022 Sep 7;17:2149-2160. doi: 10.2147/COPD.S371440. eCollection 2022. Int J Chron Obstruct Pulmon Dis. 2022. PMID: 36101790 Free PMC article.
Clinical and economic outcomes in patients with chronic obstructive pulmonary disease initiating maintenance therapy with tiotropium bromide/olodaterol or fluticasone furoate/umeclidinium/vilanterol.
Sethi S, Palli SR, Bengtson LGS, Buysman EK, Clark B, Sargent A, Shaikh A, Ferguson GT. Sethi S, et al. Among authors: clark b. J Manag Care Spec Pharm. 2023 Jul;29(7):791-806. doi: 10.18553/jmcp.2023.22373. Epub 2023 May 3. J Manag Care Spec Pharm. 2023. PMID: 37133429 Free PMC article.
Healthcare Resource Utilization, Cost and Clinical Outcomes in Patients Diagnosed with COPD Initiating Tiotropium Bromide/Olodaterol versus Fluticasone Furoate/Umeclidinium/Vilanterol Based on Exacerbation History.
Sethi S, Clark B, Bengtson LGS, Buysman EK, Palli S, Sargent A, Shaikh A, Ferguson GT. Sethi S, et al. Among authors: clark b. Int J Chron Obstruct Pulmon Dis. 2023 Apr 19;18:625-641. doi: 10.2147/COPD.S386962. eCollection 2023. Int J Chron Obstruct Pulmon Dis. 2023. PMID: 37155497 Free PMC article.
Development of a National Academic Boot Camp to Improve Fellowship Readiness.
Drake MG, Shah NG, Lee M, Brady A, Connors GR, Clark BJ, Kritek PA, McCallister JW, Burkart KM, Pedraza I, Jamieson D, Ingram JL, Lynch L, Makani SS, Siegel-Gasiewski J, Larsson EM, Zemanick ET, Liptzin DR, Good R, Crotty Alexander LE. Drake MG, et al. ATS Sch. 2020 Dec 22;2(1):49-65. doi: 10.34197/ats-scholar.2020-0091OC. ATS Sch. 2020. PMID: 33870323 Free PMC article.
Anticancer Effects of the Novel Pyrazolyl-Urea GeGe-3.
Williams A, Cooper E, Clark B, Perry L, Ponassi M, Iervasi E, Brullo C, Greenhough A, Ladomery M. Williams A, et al. Among authors: clark b. Int J Mol Sci. 2024 May 15;25(10):5380. doi: 10.3390/ijms25105380. Int J Mol Sci. 2024. PMID: 38791418
Age-related dysregulation of the retinal transcriptome in African turquoise killifish.
Bergmans S, Noel NCL, Masin L, Harding EG, Krzywańska AM, De Schutter JD, Ayana R, Hu CK, Arckens L, Ruzycki PA, MacDonald RB, Clark BS, Moons L. Bergmans S, et al. Among authors: clark bs. Aging Cell. 2024 May 14:e14192. doi: 10.1111/acel.14192. Online ahead of print. Aging Cell. 2024. PMID: 38742929 Free article.
2,883 results